Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1989-5-18
|
pubmed:abstractText |
Twelve healthy non-smokers (7M and 5F) completed a balanced three-way crossover investigation designed to characterise the influence of oral cimetidine (800 mg), ranitidine (300 mg) and placebo pretreatment for 7 days on the pharmacokinetics of a 250 mg single oral dose of theophylline. The oral clearance of theophylline after ranitidine pretreatment, 4.55 +/- 1.69 l/h (mean +/- SD) was indistinguishable from that after placebo, 4.78 +/- 1.96 l/h, but cimetidine was associated with a significant 21% reduction in theophylline clearance, 3.58 +/- 1.07 l/h (P = 0.006). There was a correspondingly significant increase in the terminal half-life of theophylline following cimetidine, 6.11 +/- 1.29 h (P = 0.017), compared with 5.05 +/- 1.43 h and 4.88 +/- 1.45 h for placebo and ranitidine, respectively. There was no change in maximum theophylline concentration or time to maximum but following cimetidine the plasma theophylline levels between 4 and 12 hours were 15-50% higher than following placebo (P less than 0.002). These data indicate a significant interaction between 800 mg cimetidine given once daily and theophylline which is likely to be the result of enzyme inhibition. Once-daily dosing with 300 mg ranitidine had no significant effect on theophylline pharmacokinetics.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0378-7966
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
201-5
|
pubmed:dateRevised |
2011-2-2
|
pubmed:meshHeading |
pubmed-meshheading:3240766-Administration, Oral,
pubmed-meshheading:3240766-Adult,
pubmed-meshheading:3240766-Cimetidine,
pubmed-meshheading:3240766-Female,
pubmed-meshheading:3240766-Humans,
pubmed-meshheading:3240766-Male,
pubmed-meshheading:3240766-Ranitidine,
pubmed-meshheading:3240766-Sex Factors,
pubmed-meshheading:3240766-Theophylline
|
pubmed:articleTitle |
The effects of once-daily dosing with ranitidine and cimetidine on theophylline pharmacokinetics.
|
pubmed:affiliation |
Drug Development (Scotland) Limited, Ninewells Hospital and Medical School, Dundee.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial
|